Zoledronic Acid Accelerates ER Stress-Mediated Inflammation by Increasing PDE4B Expression in Bisphosphonate-Related Osteonecrosis of the Jaw
Tóm tắt
Long-term administration of bisphosphonates can lead to a significant side effect known as bisphosphonate-related osteonecrosis of the jaw (BRONJ). Although macrophage-mediated inflammation has been established as an important factor in BRONJ, the underlying mechanism remains elusive. In the current study, the roles of endoplasmic reticulum (ER) stress in zoledronic acid (ZOL)-induced inflammation were analyzed in macrophages, and the regulatory mechanism of ER stress activation was next investigated. An in vitro model of BRONJ was established by treating RAW264.7 cells with ZOL. The activation of ER stress was analyzed by western blotting and transmission electron microscopy, and inflammation was assessed by quantitative real-time PCR and enzyme-linked immunosorbent assay. ER stress was significantly activated in ZOL-treated macrophages, and inhibition of ER stress by TUDCA, an ER stress inhibitor, suppressed ZOL-induced inflammation in macrophages. Mechanistically, phosphodiesterase 4B (PDE4B) was significantly increased in ZOL-treated macrophages. Forced expression of PDE4B promoted ER stress and inflammation, whereas PDE4B knockdown decreased ZOL-induced ER stress and inflammation in macrophages. More importantly, PDE4B inhibitor could improve ZOL-induced BRONJ in vivo. These data suggest that ZOL accelerates ER stress-mediated inflammation in BRONJ by increasing PDE4B expression. PDE4B inhibition may represent a potential therapeutic strategy for BRONJ. Subsequent research should concentrate on formulating medications that selectively target PDE4B, thereby mitigating the risk of BRONJ in patients undergoing bisphosphonate treatment.
Từ khóa
Tài liệu tham khảo
Wang, L., Fang, D., Xu, J., & Luo, R. (2020). Various pathways of zoledronic acid against osteoclasts and bone cancer metastasis: A brief review. BMC Cancer, 20, 1059.
Singer, F. R. (2020). The evaluation and treatment of Paget’s disease of bone. Best Practice & Research Clinical Rheumatology, 34, 101506.
Dwan, K., Phillipi, C. A., Steiner, R. D., & Basel, D. (2016). Bisphosphonate therapy for osteogenesis imperfecta. Cochrane Database of Systematic Reviews, 10, CD005088.
Endo, Y., Kumamoto, H., Nakamura, M., Sugawara, S., Takano-Yamamoto, T., Sasaki, K., & Takahashi, T. (2017). Underlying mechanisms and therapeutic strategies for bisphosphonate-related osteonecrosis of the jaw (BRONJ). Biological &/and Pharmaceutical Bulletin, 40, 739–750.
Koth, V. S., Figueiredo, M. A., Salum, F. G., & Cherubini, K. (2016). Bisphosphonate-related osteonecrosis of the jaw: from the sine qua non condition of bone exposure to a non-exposed BRONJ entity. Dento Maxillo Facial Radiology, 45, 20160049.
Campisi, G., Di Fede, O., Musciotto, A., Lo Casto, A., Lo Muzio, L., Fulfaro, F., Badalamenti, G., Russo, A., & Gebbia, N. (2007). Bisphosphonate-related osteonecrosis of the jaw (BRONJ): Run dental management designs and issues in diagnosis. Annals of Oncology, 18(Suppl 6), vi168-172.
Yunna, C., Mengru, H., Lei, W., & Weidong, C. (2020). Macrophage M1/M2 polarization. European Journal of Pharmacology, 877, 173090.
Yao, Y., Cai, X., Ren, F., Ye, Y., Wang, F., Zheng, C., Qian, Y., & Zhang, M. (2021). The macrophage-osteoclast axis in osteoimmunity and osteo-related diseases. Frontiers in Immunology, 12, 664871.
Boniakowski, A. E., Kimball, A. S., Jacobs, B. N., Kunkel, S. L., & Gallagher, K. A. (2017). Macrophage-mediated inflammation in normal and diabetic wound healing. The Journal of Immunology, 199, 17–24.
Loi, F., Cordova, L. A., Pajarinen, J., Lin, T. H., Yao, Z., & Goodman, S. B. (2016). inflammation, fracture and bone repair. Bone, 86, 119–130.
Shen, X., Zhu, W., Zhang, P., Fu, Y., Cheng, J., Liu, L., Xu, R., & Jiang, H. (2022). Macrophage miR-149–5p induction is a key driver and therapeutic target for BRONJ. JCI Insight, 7(16), e159865. https://doi.org/10.1172/jci.insight.159865
Shen, X., Shen, X., Li, B., Zhu, W., Fu, Y., Xu, R., Du, Y., Cheng, J., & Jiang, H. (2021). Abnormal macrophage polarization impedes the healing of diabetes-associated tooth sockets. Bone, 143, 115618.
Csordas, G., Weaver, D., & Hajnoczky, G. (2018). Endoplasmic reticulum-mitochondrial contactology: Structure and signaling functions. Trends in Cell Biology, 28, 523–540.
Rowland, A. A., & Voeltz, G. K. (2012). Endoplasmic reticulum-mitochondria contacts: function of the junction. Nature Reviews Molecular Cell Biology, 13, 607–625.
Qi, Z., & Chen, L. (2019). Endoplasmic reticulum stress and autophagy. Advances in Experimental Medicine and Biology, 1206, 167–177.
Koksal, A. R., Verne, G. N., & Zhou, Q. (2021). Endoplasmic reticulum stress in biological processing and disease. Journal of Investigative Medicine, 69, 309–315.
Cao, S. S. (2015). Endoplasmic reticulum stress and unfolded protein response in inflammatory bowel disease. Inflammatory Bowel Diseases, 21, 636–644.
Lindholm, D., Korhonen, L., Eriksson, O., & Koks, S. (2017). Recent insights into the role of unfolded protein response in ER stress in health and disease. Frontiers in Cell and Developmental Biology, 5, 48.
Adams, C. J., Kopp, M. C., Larburu, N., Nowak, P. R., & Ali, M. M. U. (2019). Structure and molecular mechanism of ER stress signaling by the unfolded protein response signal activator IRE1. Frontiers in Molecular Biosciences, 6, 11.
Walter, P., & Ron, D. (2011). The unfolded protein response: from stress pathway to homeostatic regulation. Science, 334, 1081–1086.
Wu, T., Jiang, Y., Shi, W., Wang, Y., & Li, T. (2023). Endoplasmic reticulum stress: a novel targeted approach to repair bone defects by regulating osteogenesis and angiogenesis. Journal of Translational Medicine, 21, 480.
Iyer, S., & Adams, D. J. (2023). Bone and the unfolded protein response: in sickness and in health. Calcified Tissue International, 113, 96–109.
Diaz-Bulnes, P., Saiz, M. L., Lopez-Larrea, C., & Rodriguez, R. M. (2019). Crosstalk between hypoxia and ER stress response: a key regulator of macrophage polarization. Frontiers in Immunology, 10, 2951.
Aghaloo, T. L., Kang, B., Sung, E. C., Shoff, M., Ronconi, M., Gotcher, J. E., Bezouglaia, O., Dry, S. M., & Tetradis, S. (2011). Periodontal disease and bisphosphonates induce osteonecrosis of the jaws in the rat. Journal of Bone and Mineral Research, 26, 1871–1882.
Wang, R., Zhang, W., Ma, H., Zou, D., Zhang, Z., & Wang, S. (2022). Structural insights into the binding of zoledronic acid with RANKL via computational simulations. Frontiers in Molecular Biosciences, 9, 992473.
Livak, K. J., & Schmittgen, T. D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods, 25, 402–408.
Chen, Y., Zhang, X., Yang, J., Feng, W., Deng, G., Xu, S., & Guo, M. (2023) Extracellular vesicles derived from selenium-deficient MAC-T cells aggravated inflammation and apoptosis by triggering the endoplasmic reticulum (ER) stress/PI3K-AKT-mTOR pathway in bovine mammary epithelial cells. Antioxidants (Basel), 12(12), 2077. https://doi.org/10.3390/antiox12122077
Xu, B., Qin, Y., Li, D., Cai, N., Wu, J., Jiang, L., Jie, L., Zhou, Z., Xu, J., & Wang, H. (2020). Inhibition of PDE4 protects neurons against oxygen-glucose deprivation-induced endoplasmic reticulum stress through activation of the Nrf-2/HO-1 pathway. Redox Biology, 28, 101342.
Chen, X., Zhu, W., Xu, R., Shen, X., Fu, Y., Cheng, J., Liu, L., & Jiang, H. (2021). Geranylgeraniol restores zoledronic acid-induced efferocytosis inhibition in bisphosphonate-related osteonecrosis of the jaw. Frontiers in Cell and Developmental Biology, 9, 770899.
Zhu, W., Xu, R., Du, J., Fu, Y., Li, S., Zhang, P., Liu, L., & Jiang, H. (2019). Zoledronic acid promotes TLR-4-mediated M1 macrophage polarization in bisphosphonate-related osteonecrosis of the jaw. The FASEB Journal, 33, 5208–5219.
Yang, X., Xu, X., Chen, J., Wang, Q., Wang, G., Ai, X., Wang, X., & Pan, J. (2020). Zoledronic acid regulates the synthesis and secretion of IL-1beta through histone methylation in macrophages. Cell Death Discovery, 6, 47.
Iwasaki, Y., Suganami, T., Hachiya, R., Shirakawa, I., Kim-Saijo, M., Tanaka, M., Hamaguchi, M., Takai-Igarashi, T., Nakai, M., Miyamoto, Y., & Ogawa, Y. (2014). Activating transcription factor 4 links metabolic stress to interleukin-6 expression in macrophages. Diabetes, 63, 152–161.
Woo, C. W., Cui, D., Arellano, J., Dorweiler, B., Harding, H., Fitzgerald, K. A., Ron, D., & Tabas, I. (2009). Adaptive suppression of the ATF4-CHOP branch of the unfolded protein response by toll-like receptor signalling. Nature Cell Biology, 11, 1473–1480.
Ghosh, A. K., Garg, S. K., Mau, T., O’Brien, M., Liu, J., & Yung, R. (2015). Elevated endoplasmic reticulum stress response contributes to adipose tissue inflammation in aging. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 70, 1320–1329.
Su, Y., Ding, J., Yang, F., He, C., Xu, Y., Zhu, X., Zhou, H., & Li, H. (2022). The regulatory role of PDE4B in the progression of inflammatory function study. Frontiers in Pharmacology, 13, 982130.
Komatsu, K., Lee, J. Y., Miyata, M., Hyang Lim, J., Jono, H., Koga, T., Xu, H., Yan, C., Kai, H., & Li, J. D. (2013). Inhibition of PDE4B suppresses inflammation by increasing expression of the deubiquitinase CYLD. Nature Communications, 4, 1684.
Avila, D. V., Myers, S. A., Zhang, J., Kharebava, G., McClain, C. J., Kim, H. Y., Whittemore, S. R., Gobejishvili, L., & Barve, S. (2017). Phosphodiesterase 4b expression plays a major role in alcohol-induced neuro-inflammation. Neuropharmacology, 125, 376–385.
Myers, S. A., Gobejishvili, L., SaraswatOhri, S., Garrett Wilson, C., Andres, K. R., Riegler, A. S., Donde, H., Joshi-Barve, S., Barve, S., & Whittemore, S. R. (2019). Following spinal cord injury, PDE4B drives an acute, local inflammatory response and a chronic, systemic response exacerbated by gut dysbiosis and endotoxemia. Neurobiology of Disease, 124, 353–363.